Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2016 Jul 1;22(10):1792–1800. doi: 10.1016/j.bbmt.2016.06.023

Table 3.

Outcomes by treatment arm for patients who achieved CR following allo-SCT.

Arm Number (%) Variable Value Number (%)
Arm 1 18 (26%) NRM Yes 2 (11%)
No 16 (89%)
Progression Yes 6 (33%)
No 12 (67%)
Death Yes 8 (44%)
No 10 (56%)
Arm 2 7 (10%) NRM Yes 1 (14%)
No 6 (86%)
Progression Yes 4 (57%)
No 3 (43%)
Death Yes 6 (86%)
No 1 (14%)
Arm 3 29 (41%) NRM Yes 5 (17%)
No 24 (83%)
Progression Yes 14 (48%)
No 15 (52%)
Death Yes 16 (55%)
No 13 (45%)
Arm 4 16 (23%) NRM Yes 1 (6%)
No 15 (94%)
Progression Yes 5 (31%)
No 11 (69%)
Death Yes 6 (38%)
No 10 (62%)